Pablo Eduardo Pereira Dutra (Pablo E P Dutra)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Cataract Surgery

Fluorescent Probe

Top Venues

Journal of clinical psychopharmacology

Molecular psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Pablo Eduardo Pereira Dutra, Laiana Azevedo Quagliato, Natia Horato, Cristiane Pereira de Souza, Bruna Dantas Dias da Silva, Antonio Egidio Nardi
You Shall Not Turn a Blind Eye to Intraocular Pressure: A Case Report of Comorbid Panic Disorder and Angle-Closure Glaucoma. Journal of clinical psychopharmacology (2024)
Pablo Eduardo Pereira Dutra, Laiana Azevedo Quagliato, Natia Horato, Cristiane Pereira de Souza, Bruna Dantas Dias da Silva, Antonio Egidio Nardi
You Shall Not Turn a Blind Eye to Intraocular Pressure: A Case Report of Comorbid Panic Disorder and Angle-Closure Glaucoma. Journal of clinical psychopharmacology 44 (4) (2024)
Pablo Eduardo Pereira Dutra, Marleide da Mota Gomes, Mauro Vitor Mendlowicz, Akos Heinemann, Antonio Egidio Nardi
Celebration of the Sesquicentennial of Otto Loewi (1873-1961): The Nobel Prize Laureate Physiologist and Pharmacologist. Molecular psychiatry (2024)
Pablo Eduardo Pereira Dutra, Laiana Azevedo Quagliato, Natia Horato, Cristiane Pereira de Souza, Bruna Dantas Dias da Silva, Antonio Egidio Nardi
You Shall Not Turn a Blind Eye to Intraocular Pressure: A Case Report of Comorbid Panic Disorder and Angle-Closure Glaucoma. Journal of clinical psychopharmacology 44 (4) (2024)
Pablo Eduardo Pereira Dutra, Richard Balon, Antonio Egidio Nardi
Celebrating 70 Years of the First Publication on Antipsychotic Treatment in North America by Heinz E. Lehmann and Gorman E. Hanrahan: Would Their Methodology Still Be Conceivable? Journal of clinical psychopharmacology 44 (1) (2023)
Pablo Eduardo Pereira Dutra, Laiana Azevedo Quagliato, Antonio Egidio Nardi
Improving the perception of respect for and the dignity of inpatients: a systematic review. BMJ open 12 (5) (2022)